Literature DB >> 17599316

The influence of hormonal contraceptive use on HIV-1 transmission and disease progression.

Jared M Baeten1, Ludo Lavreys, Julie Overbaugh.   

Abstract

Women account for nearly one-half of new human immunodeficiency virus type 1 (HIV-1) infections worldwide, including the majority of infections in Africa. Biological and epidemiological studies suggest that hormonal contraceptive use could influence susceptibility to HIV-1, as well as infectivity and disease progression for those who become infected. However, not all studies have shown this relationship, and many questions remain. Safe and effective contraceptive choices are essential for women with and at risk for HIV-1 infection. Thus, understanding the effect, if any, of hormonal contraception on HIV-1 disease among women is a public health priority.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17599316     DOI： 10.1086/519432

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  28 in total

1.  Concordance of self-reported hormonal contraceptive use and presence of exogenous hormones in serum among African women.

Authors:  Maria Pyra; Jairam R Lingappa; Renee Heffron; David W Erikson; Steven W Blue; Rena C Patel; Kavita Nanda; Helen Rees; Nelly R Mugo; Nicole L Davis; Athena P Kourtis; Jared M Baeten
Journal:  Contraception       Date:  2018-02-17       Impact factor: 3.375

2.  Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

Authors:  Charles S Morrison; Pai-Lien Chen; Immaculate Nankya; Anne Rinaldi; Barbara Van Der Pol; Yun-Rong Ma; Tsungai Chipato; Roy Mugerwa; Megan Dunbar; Eric Arts; Robert A Salata
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

Review 3.  Clinical parameters essential to methodology and interpretation of mucosal responses.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Am J Reprod Immunol       Date:  2011-01-12       Impact factor: 3.886

Review 4.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 5.  Comparison of the vaginal environment of Macaca mulatta and Macaca nemestrina throughout the menstrual cycle.

Authors:  Sarah V Hadzic; Xiaolei Wang; Jason Dufour; Lara Doyle; Preston A Marx; Andrew A Lackner; Daniel B Paulsen; Ronald S Veazey
Journal:  Am J Reprod Immunol       Date:  2014-02-13       Impact factor: 3.886

Review 6.  Contraception for HIV-Infected Adolescents.

Authors:  Athena P Kourtis; Ayesha Mirza
Journal:  Pediatrics       Date:  2016-09       Impact factor: 7.124

7.  Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.

Authors:  Stewart E Reid; James Y Dai; Jing Wang; Bupe N Sichalwe; Godspower Akpomiemie; Frances M Cowan; Sinead Delany-Moretlwe; Jared M Baeten; James P Hughes; Anna Wald; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2010-04       Impact factor: 3.731

8.  Depo-provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus.

Authors:  Meritxell Genescà; Michael B McChesney; Christopher J Miller
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

9.  Contraceptive use and method preference among women in Soweto, South Africa: the influence of expanding access to HIV care and treatment services.

Authors:  Angela Kaida; Fatima Laher; Steffanie A Strathdee; Deborah Money; Patricia A Janssen; Robert S Hogg; Glenda Gray
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

Review 10.  A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle.

Authors:  Charles R Wira; John V Fahey
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.